Australian (ASX) Stock Market Forum

AN1 - Anagenics Limited

They seem to have acquired some major US retail partners, Neiman Marcus, Bloomingdales, and by all accounts Macy's as well. Expansion into Europe is being led by Douglas. Europe is very strict about claims made on products and they must do what is claimed.
Douglas has 2400 stores scattered throughout the EU and GB.
The CEO of Douglas apparently uses Evolis and gave it the big thumbs up on the initial launch in Germany.
Evolis immediately sold out.
 
On December 15th, 2021, Cellmid Limited (CDY) changed its name and ASX code to Anagenics Limited (AN1).
 
● Cellmid acquired 100% of BLC Cosmetics from HGL Limited (ASX:HNG)
● Cellmid paid $3M in the first tranche; $1M in cash and $2M through the issue of 32,786,885 shares at 6.1cps, at a 6 X EBITDA valuation
● Cellmid may also pay a second tranche, based on an increase in BLC’s FY2022 EBITDA, excluding synergies
● The second tranche will be calculated as 3 x BLC’s audited incremental EBITDA growth, and payable in cash and shares
● The 32,786,885 shares issued to HGL are the subject of a voluntary escrow agreement for 24 months
● The effective date of the transaction was 01 October 2021
● HGL nominated representative director Phil Christopher to the board

Scale in market with doubling of Cellmid’s FY2021 revenue and other income of $7.3M
● The combined group will have $13M pro forma annualised revenue based on results at 30 June 2021 (unaudited)

● ○ BLC’s brands sold to Cellmid’s customer base and channels ○ Cross-selling of Cellmid’s own brands into BLC’s professional channels in Australia and New Zealand ○ Cross promotion on the combined digital platforms ○ Warehousing, shipping and fulfillment ○ New ERP system ○ Administrative costs
 
ΑΝΑΓΕΝΝΗΣΗ - ANAGENNISI

Anagennisi, the inspiration behind our new name Anagenics, is the Greek word for regeneration. The word is meaningful to our next stage of corporate development in three fundamental ways:
With the sale of Lyramid we have completed the transition of Cellmid into a health and beauty tech business. We are ready to REGENERATE using our strong building blocks of differentiated brands, global distribution footprint, growing revenue and profitability in sight.
• Anagen is the growth phase of the hair cycle, which is also the target of our proprietary FGF5 inhibitor technology. We are the only company in the world to have a direct affect on the anagen phase, and REGENERATE a healthy hair cycle.
• We are targeting aging and our mission is to contribute to health and youthful longevity. We plan to establish a marketplace where people can easily access their preferred products or services to REGENERATE.
 
● Cellmid acquired 100% of BLC Cosmetics from HGL Limited (ASX:HNG)
● Cellmid paid $3M in the first tranche; $1M in cash and $2M through the issue of 32,786,885 shares at 6.1cps, at a 6 X EBITDA valuation
● Cellmid may also pay a second tranche, based on an increase in BLC’s FY2022 EBITDA, excluding synergies
● The second tranche will be calculated as 3 x BLC’s audited incremental EBITDA growth, and payable in cash and shares
● The 32,786,885 shares issued to HGL are the subject of a voluntary escrow agreement for 24 months
● The effective date of the transaction was 01 October 2021
● HGL nominated representative director Phil Christopher to the board

Scale in market with doubling of Cellmid’s FY2021 revenue and other income of $7.3M
● The combined group will have $13M pro forma annualised revenue based on results at 30 June 2021 (unaudited)

● ○ BLC’s brands sold to Cellmid’s customer base and channels ○ Cross-selling of Cellmid’s own brands into BLC’s professional channels in Australia and New Zealand ○ Cross promotion on the combined digital platforms ○ Warehousing, shipping and fulfillment ○ New ERP system ○ Administrative costs
Is that a 1 or an i after AN. ?

I’m more acquainted with Latin than the Greek.

Who am I to comment on the chances of a vanity product in times of plague however?

gg
 
Is that a 1 or an i after AN. ?
a 1
I’m more acquainted with Latin than the Greek.
Consciously didn't put it in italics.

..... plenty of neologisms to chomp on. "A health and beauty-tech business growing shareholder value through the global distribution and sales of its proprietary brands of differentiated, clinically validated anti-aging solutions and exclusive distribution of international cosmeceutical and wellness brands".
Who am I to comment on the chances of a vanity product in times of plague however?
there's always room for the discretionary (cosmeceutical-as-a-service) spend!
 
Top